Mrs. Ying Yang | Innovative Leadership | Outstanding Scientist Award

Mrs. Ying Yang | Innovative Leadership | Outstanding Scientist Award

Binzhou Medical University, China

Profile 

Scopus

Early Academic Pursuits 📚

Ying Yang’s academic journey began with a strong foundation in clinical medicine, earning his BM (Bachelor of Medicine) from Nanchang University in 2009. His early education in the Department of Clinical Medicine laid the groundwork for his deep engagement in medical sciences, specifically focusing on hearing and speech rehabilitation. Following his bachelor’s degree, Yang continued his studies by pursuing a Master’s in Medicine (MM) in the Department of Otolaryngology at Nanchang University, where he honed his expertise in ear, nose, and throat (ENT) medicine. This phase of his education was crucial, allowing him to explore the intricacies of auditory and speech-related disorders.

Yang’s thirst for knowledge and research continued as he progressed to a PhD in Speech and Hearing Sciences at East China Normal University, completing his doctoral studies in 2014. His doctoral research marked a significant milestone in his academic career, as it bridged the gap between clinical medicine and advanced speech and hearing rehabilitation techniques. These early academic pursuits positioned him as a promising figure in the field of rehabilitation sciences, paving the way for his future professional endeavors.

Professional Endeavors 💼

After completing his PhD, Professor Ying Yang embarked on an illustrious academic career, joining Binzhou Medical University in Shandong, China, where he remains a key figure in the Department of Hearing and Speech Rehabilitation. He started as a Lecturer in 2016 and quickly ascended to the position of Associate Professor by 2019. His extensive experience in the field led to his promotion to full Professor in 2024, marking a new phase in his career.

In addition to his academic role, Yang has contributed to the National Natural Science Foundation of China, serving as an Associate Professor in the Department of Otolaryngology of Medicine. His diverse experience across different academic positions has allowed him to shape the direction of research in hearing and speech rehabilitation, mentoring the next generation of specialists in the field. His work at Binzhou Medical University has had a significant impact, influencing the development of new therapies and methods for treating auditory and speech impairments.

Contributions and Research Focus 🔬

Professor Yang’s primary research interests lie in auditory-speech rehabilitation technology, specifically focusing on congenital deafness and other speech-related disorders. His doctoral research explored the intersection of speech and hearing sciences, emphasizing technological interventions to improve outcomes for individuals with auditory impairments.

In 2017, Yang’s groundbreaking work in auditory-speech rehabilitation for congenital deafness earned him the 3rd Award of Disability Prevention and Rehabilitation Science and Technology Award from the China Rehabilitation Association for the Disabled People. This recognition highlights his pioneering research on the development of an auditory-speech rehabilitation technology system, which has greatly enhanced treatment methods for congenital deafness. His commitment to integrating advanced medical technologies with speech rehabilitation systems has positioned him as a leader in the field.

Professor Yang’s work also includes advancing rehabilitation strategies for a variety of hearing impairments, using a multidisciplinary approach that incorporates both medical treatment and speech therapy. His research in auditory rehabilitation technology has significant implications for improving the quality of life for those affected by hearing and speech disorders.

Accolades and Recognition 🏆

Throughout his career, Professor Ying Yang has received numerous accolades for his work in medical education and rehabilitation sciences. In 2020, he was honored as the Excellent Advisor for Students by the Chinese Medical Association of Rehabilitation Science Popularization Working Committee. This award recognized his exceptional mentorship and guidance for students pursuing careers in rehabilitation science.

Yang’s contributions to the field of teaching were further acknowledged in 2021, when he was awarded the 2nd and 3rd Awards of Teaching Achievement. This honor highlights his excellence in education, where he not only teaches but also develops innovative methods and practices to improve the learning experience for his students.

These awards and recognitions underscore his status as a leading figure in the rehabilitation sciences community and reflect the deep impact he has had on both the academic and practical sides of the field.

Impact and Influence 🌍

Professor Ying Yang’s work has had a far-reaching impact, particularly in the area of auditory and speech rehabilitation. His research on congenital deafness and speech rehabilitation technology systems has paved the way for significant advancements in treatment methods. Through his contributions, many individuals with auditory impairments have experienced improved outcomes, particularly in terms of communication and speech abilities.

His professional influence extends beyond academic circles, as his work has shaped public policies and strategies in the rehabilitation sector. As a mentor, he has influenced a new generation of rehabilitation professionals, equipping them with the knowledge and skills necessary to advance the field. Yang’s impact is also evident in the collaborative research projects he has led, which involve interdisciplinary teams working to develop cutting-edge solutions for hearing and speech rehabilitation.

Legacy and Future Contributions 🌟

Professor Ying Yang’s legacy is firmly rooted in his commitment to improving the lives of individuals with hearing and speech impairments. His pioneering research and contributions to auditory-speech rehabilitation have created a foundation for future advancements in the field. As he continues his work at Binzhou Medical University, his research is likely to expand into new areas, including the application of artificial intelligence in speech therapy and the development of more personalized rehabilitation techniques.

In the future, Yang aims to further integrate advanced technologies, such as cochlear implants and virtual rehabilitation systems, into mainstream medical practices. His work is set to influence global trends in speech and hearing rehabilitation, ensuring that those with hearing impairments can lead more independent and fulfilling lives.

With his deep expertise, dedication to research, and commitment to education, Professor Ying Yang is poised to leave a lasting impact on the field of hearing and speech rehabilitation for years to come. His future contributions will continue to shape the landscape of medical rehabilitation, cementing his legacy as a key figure in this transformative field.

📝Notable Publications

Evidence for early encoding of speech in blind people

Authors: Liu, Y.-L., Zhang, Y.-X., Wang, Y., Yang, Y.
Year: 2024

Cross-cultural adaptation, reliability, and validity of the Chinese version of the Acceptance and Action Questionnaire-Management of Child Hearing Loss

Authors: Xiao, Y., Liu, Y., Han, J., Sun, X., Yang, Y.
Journal: International Journal of Audiology
Year: 2024

Ferroptosis is involved in PGPS-induced otitis media in C57BL/6 mice

Authors: Yan, B., Xie, D., Wu, Y., Li, B., Zheng, Q.
Journal: Cell Death Discovery
Year: 2022

Auditory Discrimination Elicited by Nonspeech and Speech Stimuli in Children With Congenital Hearing Loss

Authors: Yang, Y., Li, Q., Xiao, Y., Li, B., Zheng, Q.
Journal: Journal of Speech, Language, and Hearing Research
Year: 2022

Behavioral compliance with preventive health measures for students with and without hearing disability during COVID-19 pandemic: A cross-sectional study

Authors: Yang, Y., Liu, Y., Xiao, Y., Qu, C., Jen, P.H.S.
Journal: Frontiers in Public Health
Year: 2022

 

 

Prof Dr. Chi-Tai Yeh | Innovative Leadership | Excellence in Research | 2803

Prof Dr. Chi-Tai Yeh | Innovative Leadership | Excellence in Research

Prof Dr. Chi-Tai Yeh,Taipei Medical University-Shuang Ho Hospital,

 Professional Profile

Education 🎓

  • Post-Doctoral Fellow | Jan 2006 – Jan 2010
    National Institute of Cancer Research, Taiwan (R.O.C)
    National Health Research Institutes
  • Ph.D. in Food Science and Biotechnology | Aug 2001 – Aug 2005
    National Chung Hsing University, Taiwan (R.O.C)

Current Positions 📈

  • Professor | Apr 2021 – Present
    Continuing Education Program of Food Biotechnology Applications, College of Science and Engineering, National Taitung University, Taiwan (R.O.C)
  • Joint Appointment Research Fellow and Executive Secretary | Feb 2014 – Present
    Department of Research, Taipei Medical University – Shuang Ho Hospital, Taiwan (R.O.C)
  • Assistant Professor | Apr 2010 – Present
    Graduate Institute of Clinical Medicine, Taipei Medical University, Taiwan (R.O.C)

Professional Appointments and Experience 💼

  • Authored 91 articles in cancer and nutritional chemistry journals 📄
  • Contributed to 2 book chapters 📚
  • Secured 6 patents in cancer therapy compounds 🔬
  • Research Focus:
    • Cancer cell biology
    • Cancer stem cell studies
    • Nutrigenomics
    • Cancer prevention using dietary phytochemicals 🍎
  • Key Objectives:
    • Disrupt tumor growth and survival pathways
    • Enhance chemosensitivity and/or radiosensitivity
    • Develop methods to counter tumor metastasis
    • Test therapeutic interventions with tumor metastasis suppressor genes in preclinical trials
    • Employ high-throughput proteomic analysis to discover new tumor metastasis markers and evaluate therapeutic approaches

Notable Achievements 🏆

  • 5292 Citations 📈
  • h-Index: 42 🎖️
  • Developed new methods to counter tumor metastasis and enhance treatment efficacy in cancer therapy

Publication Top Noted:

  • Paper Title: PAICS/DYRK3 Multienzyme Interactions as Coregulators of Purinosome Formation and Metabolism on Radioresistance in Oral Squamous Cell Carcinoma
  • Paper Title: Tumor-Associated Macrophages Affect the Tumor Microenvironment and Radioresistance via the Upregulation of CXCL6/CXCR2 in Hepatocellular Carcinoma
  • Paper Title:  Furanocoumarin Notopterol: Inhibition of Hepatocellular Carcinogenesis through Suppression of Cancer Stemness Signaling and Induction of Oxidative Stress-Associated Cell Death
  • Paper Title: Correction: Chen et al. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis. Cancers 2021, 13, 3227
  • Paper Title: Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression